Publication Cover
Accountability in Research
Ethics, Integrity and Policy
Volume 25, 2018 - Issue 1
259
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Clarifying the concept of the “Social” in risk assessments for human subjects research

, Ph.D. & , Ph.D.

References

  • Arendt, H. 1958. The Human Condition. Chicago, IL: University of Chicago Press.
  • Bhagianadh, D., S. Bandekar, D. Ravindran, and S. Nikarge. 2010. This is no low risk game: Social science researchers reflect on their work. Indian Journal of Medical Ethics 7 (1):54–55.
  • Bosk, C. L., and R. G. De Vries. 2004. Bureaucracies of mass deception: Institutional review boards and the ethics of ethnographic research. Annals of the American Academy of Political and Social Science 595:249–63. (ArticleType: research-article/Issue Title: Being Here and Being There: Fieldwork Encounters and Ethnographic Discoveries/Full publication date: Sep., 2004/Copyright © 2004 American Academy of Political and Social Science) doi:10.1177/0002716204266913.
  • Churchill, L. R., D. K. Nelson, G. E. Henderson, N. M. King, A. M. Davis, E. Leahey, and B. S. Wilfond. 2003. Assessing benefits in clinical research: Why diversity in benefit assessment can be risky. IRB; a Review of Human Subjects Research 25 (3):1–8.
  • Committee, A. 2000. Institutional review boards and social science research. American Association of University Professors, Washington, DC. http://www.aaup.org.AAUP/comm/rep/A/protecting.htm.
  • Committee, A. 2006. Research on human subjects: academic freedom and the institutional review board, Washington, DC. http://www.aaup.org/AAUP/comm/rep/A/humansubs.htm.
  • Council for International Organizations of Medical Sciences. 2002. International ethical guidelines for biomedical research involving human subjects. Geneva, Switzerland: World Health Organization.
  • Cunningham-Burley, S. 2006. Public knowledge and public trust. Community Genetics 9 (3):204–10.
  • Dressler, L. G. 2009. Disclosure of research results from cancer genomic studies: State of the science. Clinical Cancer Research 15 (13):4270–76. doi:10.1158/1078-0432.CCR-08-3067.
  • Enserink, M. 2011. Dutch univeristy sacks social psychologist over faked data. Science Magazine. http://www.sciencemag.org/news/2011/09/dutch-university-sackssocial-psychologist-over-faked-data.
  • Emanuel, E. 2012. The systematic assessment of research risks: Does it depend upon culture or context? In 2nd Asia Pacific Research Ethics Conference. Singapore, Singapore: National Health Group of Singapore.
  • Facio, F. M., S. Brooks, J. Loewenstein, S. Green, L. G. Biesecker, and B. B. Biesecker. 2011. Motivators for participation in a whole-genome sequencing study: Implications for translational genomics research. European Journal of Human Genetics 19 (12):1213–17. doi:10.1038/ejhg.2011.123.
  • Godlee, F., J. Smith, and H. Marcovitch. 2011. Wakefield’s article linking MMR vaccine and autism was fraudulent. BMJ 342:c7452. doi:10.1136/bmj.c7452.
  • Grayson, J. P., and R. Myles. 2005. How research ethics boards are undermining survey research on Canadian university students. Journal of Academic Ethics 2 (4):293–314. doi:10.1007/s10805-005-9005-x.
  • Gunsalus, C. K. 2004. The Nanny state meets the inner lawyer: Overregulating while underprotecting human participants in research. Ethics and Behavior 14 (4):369–82. doi:10.1207/s15327019eb1404_7.
  • Gunsalus, C. K., E. Bruner, N. C. Burbules, L. Dash, M. Finkin, J. P. Goldber, W. T. Greenough, G. A. Miller, M. G. Pratt, and D. Aronson. 2005. The illinois white paper: Improving the system for protecting human subejcts: Counteracting IRB ‘Mission Creep’. Qualitative Inquiry 13 (5):617–49. doi:10.1177/1077800407300785.
  • Haggerty, K. D. 2004. Ethics creep: Governing social science research in the name of ethics. Qualitative Sociology 27 (4):391–414. doi:10.1023/B:QUAS.0000049239.15922.a3.
  • Hammersley, M. 2009. Against the ethicists: On the evils of ethical regulation. International Journal of Social Research Methodology 12 (3):211–25. doi:10.1080/13645570802170288.
  • Hayek, F. A. 1967. Studies in philosophy, politics, and economics. Chicago, IL: University of Chicago Press.
  • Hayek, F. A. 1988. The fatal conceit: The errors of socialism. Chicago, IL: University of Chicago Press.
  • Heeney, C., N. Hawkins, J. De Vries, P. Boddington, and J. Kaye. 2011. Assessing the privacy risks of data sharing in genomics. Public Health Genomics 14 (1): 17–25.
  • Hero, R. E. 2007. Racial diversity and social capital: Equality and community in America. Cambridge, UK: Cambridge University Press.
  • Hoedemaekers, R., B. Gordijn, and M. Pijnenburg. 2007. Solidarity and justice as guiding principles in genomic research. Bioethics 21 (6):342–50. doi:10.1111/biot.2007.21.issue-6.
  • Ioannidis, J. P. A. 2012. Why science is not necessarily self-correcting. Perspectives on Psychological Science 7 (6):645–54. doi:10.1177/1745691612464056.
  • Jordan, S. R., and K. Q. Hill. 2012a. Editor’s perceptions of ethical and managerial issues in political science journals. PS: Political Science and Politics 45 (4):724–27.
  • Jordan, S. R., and K. Q. Hill. 2012b. Ethical assurance statements in political science journals. Journal of Academic Ethics 10 (3):243–50. doi:10.1007/s10805-012-9163-6.
  • Kaiser, K. 2009. Protecting respondent confidentiality in qualitative research. Qualitative Health Research 19 (11):1632–41. doi:10.1177/1049732309350879.
  • Kleinig, J. 1978. Crime and the Concept of Harm. American Philosophical Quarterly 15 (1):27–36.
  • Levine, R. J. 1975. The nature and definition of informed consent in various research settings. Preliminary paper prepared for the National Commission for the Protection of Human Subjects of Biomedical Behavioral Research, U.S. Department of Health, Education and Welfare, Washington, D.C.
  • Manasco, P. K. 2005. Ethical and legal aspects of applied genomic technologies: Practical solutions. Current Molecular Medicine 5 (1):23–28. doi:10.2174/1566524053152816.
  • McGuire, A. L., R. Fisher, P. Cusenza, K. Hudson, M. A. Rothstein, D. McGraw, S. Matteson, J. Glaser, and D. E. Henley. 2008a. Confidentiality, privacy, and security of genetic and genomic test information in electronic health records: Points to consider. Genetics in Medicine 10 (7):495–99. doi:10.1097/GIM.0b013e31817a8aaa.
  • McGuire, A. L., J. A. Hamilton, R. Lunstroth, L. B. McCullough, and A. Goldman. 2008b. DNA data sharing: Research participants’ perspectives. Genetics in Medicine 10 (1):46–53. doi:10.1097/GIM.0b013e31815f1e00.
  • McKnight, C. 2003. Medicine as an essentially contested concept. Journal of Medical Ethics 29 (4):261–62. doi:10.1136/jme.29.4.261.
  • Miller, D. 1999. Principles of Social Justice. Cambridge, MA: Harvard University Press.
  • Miller, F. G., and S. Joffe. 2009. Limits to research risks. Journal of Medical Ethicsx 35 (7):445–49. doi:10.1136/jme.2008.026062.
  • Miller, P. B., and C. Weijer. 2000. Moral solutions in assessing research risk. IRB: Ethics and Human Research 22 (5):6–10. doi:10.2307/3564222.
  • O’Reilly, M., M. Dixon-Woods, E. Angell, R. Ashcroft, and A. Bryman. 2009. Doing accountability: A discourse analysis of research ethics committee letters. Sociology of Health and Illness 31 (2):246–61. doi:10.1111/j.1467-9566.2008.01132.x.
  • Office of Behavioral and Social Sciences Research (OBSSR). No date. BSSR (Behavioral and Social Sciences Research) Definitions.https://obssr.od.nih.gov/aboutus/bssr-definition/.
  • Pitkin, H. F. 1998. Attack of the Blob: Hannah Arendt’s Concept of the Social. Chicago, IL: University of Chicago Press.
  • Porter, T. 2008. Research ethics governance and political science in Canada. PS - Political Science and Politics 41 (3):495–99. doi:10.1017/s1049096508080852.
  • Presidential Commission for the Study of Bioethical Issues. 2011. Moral science: Protecting participants in human subjects research. Washington, D.C.: US Government Printing Office.
  • Pritchard, I. A. 2011. How do IRB members make decisions? a review and research agenda. Journal of Empirical Research on Human Research Ethics 6 (2):31–46. doi:10.1525/jer.2011.6.2.31.
  • Putnam, R. D. 2000. Bowling alone: The collapse and revival of american community. New York, NY: Simon & Schuster.
  • Rasmussen, L. M. 2008. Not all research is equal: Taking social science research into account. The American Journal of Bioethics 8 (11):17–18. doi:10.1080/15265160802513119.
  • Rasmussen, L. M. 2009. Problems with minimal-risk research oversight: A threat to academic freedom? IRB Ethics and Human Research 31 (3):11–16.
  • Reddy, D. S. 2007. Good gifts for the common good: Blood and bioethics in the market of genetic research. Cultural Anthropology 22 (3):429–72. doi:10.1525/can.2007.22.3.429.
  • Resnik, D. B. 2010. Genomic research data: Open vs. restricted access. IRB Ethics and Human Research 32 (1):1–6.
  • Rid, A., E. J. Emanuel, and D. Wendler. 2010. Evaluating the risks of clinical research. JAMA - Journal of the American Medical Association 304 (13):1472–79. doi:10.1001/jama.2010.1414.
  • Rid, A., and D. Wendler. 2011a. A framework for risk-benefit evaluations in biomedical research. Kennedy Institute of Ethics Journal 21 (2):141–79. doi:10.1353/ken.2011.0007.
  • Rid, A., and D. Wendler. 2011b. A proposal and prototype for a Research Risk Repository to improve the protection of research participants. Clinical Trials 8 (6):705–15. doi:10.1177/1740774511414595.
  • Schrag, Z. 2010. Ethical imperialism: Institutional review boards and the social sciences, 1965–2009. Baltimore, MD: Johns Hopkins University Press.
  • Seligson, M. A. 2008. Human subjects protection and Large-N Research: When exempt is non-exempt and research is non-research. PS: Political Science and Politics 41 (3):477–82.
  • Sleeboom, M. 2005. The Harvard case of Xu Xiping: Exploitation of the people, scientific advance, or genetic theft? New Genetics and Society 24 (1):57–78. doi:10.1080/14636770500037776.
  • The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1975. The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research, ed. Education Department of Health, and Welfare. Washington, DC: US Government Printing Office.
  • The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. 1979. The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research—Appendix. ed. Education Department of Health and Welfare. Washington, DC: US Government Printing Office.
  • United Kingdom Research Integrity Office. 2012. Code of practice for research. UK Research Integrity Office. http://ukrio.org/publications/code-of-practice-for-research/
  • American Recovery and Reinvestment Act of 2009. 2009. Title XIII: Health Information Technology, ed. United States Congress, Washington, D.C.: Government Printing Office.
  • US Department of Health and Human Services. 2011. ANPRM for revision to common rule: Information related to advance notice of proposed rulemaking (ANPRM) for revisions to the common rule. Federal register, Vol. 76, 44512–31.
  • US Department of Health and Human Services. 2015. NPRM for federal policy for the protection of human subjects. Federal Register 80 (173):53933–4061.
  • US Department of Health and Human Services. 2017. Final rule– federal policy for the protection of human subjects. Federal Register 82 (12):7149–274.
  • Weijer, C. 1999a. The analysis of risks and potential benefits in research. NCEHR Communique = Communique CNERH 9 (2):16–20.
  • Weijer, C. 1999b. Thinking clearly about research risk: Implications of the work of Benjamin Freedman. IRB: Ethics and Human Research 21 (6):1–5. doi:10.2307/3564450.
  • Weijer, C. 2004. The ethical analysis of risk in intensive care unit research. Critical Care 8 (2):85–86. doi:10.1186/cc2822.
  • Weijer, C., and P. B. Miller. 2004. When are research risks reasonable in relation to anticipated benefits? Nature Medicine 10 (6):570–73. doi:10.1038/nm0604-570.
  • Weijer, C., and P. B. Miller. 2007. Refuting the net risks test: A response to Wendler and Miller’s “Assessing research risks systematically.” Journal of Medical Ethics 33 (8):487–90. doi:10.1136/jme.2006.016444.
  • Weijer, C. 2000. The ethical analysis of risk. Journal of Law, Medicine and Ethics 28 (4):344–61. doi:10.1111/j.1748-720X.2000.tb00686.x.
  • Wendler, D. 1998. When should “Riskier” subjects be excluded from research participation? Kennedy Institute of Ethics Journal 8 (3):307–27. doi:10.1353/ken.1998.0023.
  • Wendler, D. 2011. What we worry about when we worry about the ethics of clinical research. Theoretical Medicine and Bioethics 32 (3):161–80. doi:10.1007/s11017-011-9176-y.
  • Wendler, D., L. Belsky, K. M. Thompson, and E. J. Emanuel. 2005. Quantifying the federal minimal risk standard. Implications for pediatric research without a prospect of direct benefit. Journal of the American Medical Association 294 (7):826–32. doi:10.1001/jama.294.7.826.
  • Wendler, D., and E. J. Emanuel. 2005. What is a “minor” increase over minimal risk? The Journal of Pediatrics 147 (5):575–78. doi:10.1016/j.jpeds.2005.07.013.
  • Wendler, D., and F. G. Miller. 2007. Assessing research risks systematically: The net risks test. Journal of Medical Ethics 33 (8):481–86. doi:10.1136/jme.2005.014043.
  • Wendler, D., and S. Varma. 2006. Minimal risk in pediatric research. The Journal of Pediatrics 149 (6):855–61. doi:10.1016/j.jpeds.2006.08.064.
  • Wiles, R., V. Charles, G. P. Crow, and S. J. Heath. 2006. Researching researchers: Lessons for research ethics. Qualitative Research 6 (3):283–99. doi:10.1177/1468794106065004.
  • Wiles, R., G. Crow, S. Heath, and V. Charles. 2008. The management of confidentiality and anonymity in social research. International Journal of Social Research Methodology 11 (5):417–28. doi:10.1080/13645570701622231.
  • Winickoff, D. E. 2001. Biosamples, genomics, and human rights: Context and content of Iceland’s Biobanks Act. Journal of Biolaw and Business 4 (2):11–17.
  • Yanow, D., and P. Schwartz-Shea. 2008. Reforming institutional review board policy: Issues in implementation and field research. PS: Political Science and Politics 41 (3):483–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.